Health TrialsbyHealthPanel

HAIQU (Hospital AIr QUality)

ConditionAcute Respiratory Tract Infection
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMayo Clinic

About this trial

The purpose of this research is to assess whether integration of an aerosol biosensor and air quality risk assessment software that integrates into a building management system will improve indoor air quality metrics in hospital environments and reduces risk factors associated with respiratory disease transmission.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Mayo Clinic Staff working in ED with a minimum of .7 FTE in Midwest (MN and WI), Phoenix (AZ), or Jacksonville (FL) and patient contact.

Mayo Clinic Staff working in primary care with a minimum of .7 FTE. in Rochester (MN), Phoenix (AZ), or Jacksonville (FL) and patient contact

Disqualifiers

Any participant who does not meet either of the inclusion criteria.

Trial design

Design model

Single group

Treatments tested in this trial

  • Self-swab test

    Diagnostic test

    Participants will self-report when they are experiencing respiratory symptoms and will be asked for a self-swab to be used for data analysis.

Treatment groups

850 Participants
are divided into 1 treatment group
Group A: Emergency Department EmployeesExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Number of participants to experience acute respiratory infection (ARI) symptoms

Symptoms include: at least 2 upper respiratory symptoms for at least 24 hours; OR at least 2 symptoms that include an upper/lower respiratory symptom and a systemic symptom (fever, fatigue, body aches, headache, decreased appetite) for at least 24 hours

Time frame
3 years

Secondary outcomes

1

Number of confirmed cases of acute respiratory infections

Number of cases confirmed by at least one viral panel-positive swab detected by RT-PCR

Time frame
3 years
2

Number of confirmed cases of lower respiratory tract disease

Number of cases of lower respiratory tract disease confirmed by at least one viral panel-positive swab detected by RT-PCR

Time frame
3 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mayo Clinic

Lead sponsor

Advanced Research Projects Agency for Health

Collaborator

Roche Pharma AG

Collaborator

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: